Fausto Salaffi1, Marco Di Carlo2, Marina Carotti3, Paolo Fraticelli4, Armando Gabrielli4, Andrea Giovagnoni3. 1. Rheumatological Clinic, Ospedale "Carlo Urbani", Università Politecnica delle Marche, Via Aldo Moro, 25, 60035, Jesi, Ancona, Italy. 2. Rheumatological Clinic, Ospedale "Carlo Urbani", Università Politecnica delle Marche, Via Aldo Moro, 25, 60035, Jesi, Ancona, Italy. dica.marco@yahoo.it. 3. Department of Radiology, Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy. 4. Medical Clinic, Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy.
Abstract
OBJECTIVES: Oesophageal dilatation (OD) has been implicated in the pathogenesis of interstitial lung disease (ILD) in systemic sclerosis (SSc). The aims of this study were to explore the association of the OD and SSc-ILD on chest high-resolution computed tomography (HRCT), and to establish a cutoff point for the OD suggestive for the presence of a significant lung involvement. METHODS: The widest oesophageal diameter (WOD) was obtained on axial HRCT images. The parenchymal abnormalities on HRCT were coded and scored according to Warrick method. Patient-centred measures, pulmonary function tests and the single breath carbon monoxide diffusing capacity of the lung (DLco) were also obtained. Multivariate regression analysis was performed to identify factors associated with oesophageal diameter. RESULTS: 126 subjects with SSc were included. The mean (± SD) WOD was 13.5 (± 4.2) mm, and in 76 (60.3%) participants WOD was ≥ 11 mm. SSc patients with ILD had larger oesophageal diameters than those without lung disease (19.4 vs. 14.1 mm, p < 0.001). We observed a high correlation between WOD and gastro-oesophageal reflux disease questionnaire (GerdQ) (r = 0.886, p < 0.001), Borg score (r = 0.705, p < 0.001), and Warrick score (r = 0.614, p < 0.001). WOD negatively correlated with DLco (r = - 0.508, p < 0.001). Multivariate analysis demonstrated positive associations between WOD and GerdQ (p < 0.0001), Borg score (p < 0.0005), and total Warrick score (p = 0.019). CONCLUSION: An increased oesophageal diameter (> 11 mm) on chest HRCT is associated with pulmonary and oesophageal symptoms, more severe ILD, and lower DLco.
OBJECTIVES:Oesophageal dilatation (OD) has been implicated in the pathogenesis of interstitial lung disease (ILD) in systemic sclerosis (SSc). The aims of this study were to explore the association of the OD and SSc-ILD on chest high-resolution computed tomography (HRCT), and to establish a cutoff point for the OD suggestive for the presence of a significant lung involvement. METHODS: The widest oesophageal diameter (WOD) was obtained on axial HRCT images. The parenchymal abnormalities on HRCT were coded and scored according to Warrick method. Patient-centred measures, pulmonary function tests and the single breath carbon monoxide diffusing capacity of the lung (DLco) were also obtained. Multivariate regression analysis was performed to identify factors associated with oesophageal diameter. RESULTS: 126 subjects with SSc were included. The mean (± SD) WOD was 13.5 (± 4.2) mm, and in 76 (60.3%) participants WOD was ≥ 11 mm. SSc patients with ILD had larger oesophageal diameters than those without lung disease (19.4 vs. 14.1 mm, p < 0.001). We observed a high correlation between WOD and gastro-oesophageal reflux disease questionnaire (GerdQ) (r = 0.886, p < 0.001), Borg score (r = 0.705, p < 0.001), and Warrick score (r = 0.614, p < 0.001). WOD negatively correlated with DLco (r = - 0.508, p < 0.001). Multivariate analysis demonstrated positive associations between WOD and GerdQ (p < 0.0001), Borg score (p < 0.0005), and total Warrick score (p = 0.019). CONCLUSION: An increased oesophageal diameter (> 11 mm) on chest HRCT is associated with pulmonary and oesophageal symptoms, more severe ILD, and lower DLco.
Authors: Kerri A Johannson; Irina Strâmbu; Claudia Ravaglia; Jan C Grutters; Claudia Valenzuela; Nesrin Mogulkoc; Fabrizio Luppi; Luca Richeldi; Athol U Wells; Carlo Vancheri; Michael Kreuter Journal: Lancet Respir Med Date: 2017-07 Impact factor: 30.700
Authors: E H Pitrez; M Bredemeier; R M Xavier; K G Capobianco; V G Restelli; M V Vieira; D H C Ludwig; J C T Brenol; A P A Furtado; L M B Fonseca; B Gutfilen Journal: Br J Radiol Date: 2006-08-02 Impact factor: 3.039
Authors: M C Vonk; C E van Die; M M Snoeren; K J Bhansing; P L C M van Riel; J Fransen; F H J van den Hoogen Journal: Ann Rheum Dis Date: 2007-12-28 Impact factor: 19.103
Authors: Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff Journal: Semin Arthritis Rheum Date: 2016-02-26 Impact factor: 5.532